DBVT Q1 2025 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$4M

Operating Income

-$27M

Net Income

-$27M

EPS (Diluted)

$-1.30

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$51M

Total Liabilities

$48M

Stockholders' Equity

$3M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1M	-100.0%
Gross Profit	-$4M	$1M	-418.2%
Operating Income	-$27M	-$29M	+4.1%
Net Income	-$27M	-$27M	+0.9%